ToeFX Inc. is delighted to announce it has received approval from Health Canada for its ClearToe Therapy Light, making it the only photodynamic therapy approved by Health Canada for the treatment of onychomycosis. The product is for sale online now on the ToeFX.com website.
“We are seeing huge patient demand for a safe, painless treatment. ToeFX is a gentle therapy based on the application of light. Earning these approvals means that clinicians can buy with confidence,” said Dr Irit Van-Ham, Chief Technology Officer of ToeFX Inc. “We are focused on creating an end-to-end solution for the treatment of this extremely prevalent infection.”
According to a 2016 study by Market Research Future, the global onychomycosis market is expected to register a CAGR of 6.28% to reach 7,912.5 million by 2025.